The Medulloblastoma Initiative (MBI) was founded in 2021 through the shared vision of entrepreneur Fernando Goldsztein and Dr. Roger J. Packer of Children’s National Hospital. Dedicated to transforming the future of pediatric brain cancer research, MBI raises and directs private philanthropic funding to advance collaborative research on Group 4 medulloblastoma, the most common and least understood pediatric brain cancer. Through the Cure Group 4 Consortium, MBI unites 16 research laboratories across the United States, Canada, and Germany in pursuit of more effective, less toxic treatments.

With visibility in global media and partnerships with leading research institutions, MBI is expanding its impact by connecting visionary donors to groundbreaking science. The organization’s focus is both urgent and personal: to accelerate discoveries that give children and families a real chance at cure and quality of life.